scispace - formally typeset
Open AccessJournal ArticleDOI

Atypical Hemolytic Uremic Syndrome

TLDR
HUS is a triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure that predicts the prognosis both in native kidneys and after renal transplantation.
About
This article is published in Seminars in Nephrology.The article was published on 2013-11-01 and is currently open access. It has received 258 citations till now. The article focuses on the topics: Atypical hemolytic uremic syndrome & Eculizumab.

read more

Citations
More filters
Journal ArticleDOI

Atypical hemolytic uremic syndrome

TL;DR: Case reports and two phase II trials show an impressive efficacy of the complement C5 blocker eculizumab, suggesting it will be the next standard of care.
Journal ArticleDOI

Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

TL;DR: Recommendations for best treatment strategies were discussed at length, providing the evidence base underpinning current treatment options, and knowledge gaps were identified and a prioritized research agenda was proposed to resolve outstanding controversial issues.
Journal ArticleDOI

Complement, a target for therapy in inflammatory and degenerative diseases.

TL;DR: The history, current landscape and future directions for anti-complement therapies are described, which include infectious, inflammatory, degenerative, traumatic and neoplastic disorders.
Journal ArticleDOI

Dynamics of complement activation in aHUS and how to monitor eculizumab therapy

TL;DR: Results point to efficient complement inhibition on endothelium for aHUS treatment, including C5b-9 endothelial deposits, which might help monitor eculizumab effectiveness, avoid drug overexposure, and save money considering the extremely high cost of the drug.
References
More filters
Journal ArticleDOI

Hemolytic-uremic syndrome associated with acute Campylobacter upsaliensis gastroenteritis.

James E. Carter, +1 more
- 01 Jan 1996 - 
TL;DR: The first association of Campylobacter upsa-liensis with HUS is detailed and investigations which provide evidence against the possibility of a coinfection with verotoxigenic E.E. coli are described.
Journal ArticleDOI

A novel mutation in the complement regulator clusterin in recurrent hemolytic uremic syndrome.

TL;DR: A novel heterozygous mutation in the clusterin gene, nucleotide position A1298C (glutamine>proline Q433P), was detected in exon 7 of a child with recurrent hemolytic uremic syndrome, indicating that the mutation could lead to defective inhibition of formation of the membrane attack complex under these conditions.
Journal ArticleDOI

Renal transplantation in adults with autosomal recessive inheritance of hemolytic uremic syndrome

TL;DR: Four families in which two adult siblings were affected with HUS in each kindred are described, in which eight patients developed renal failure requiring dialysis and transplantation, and seven patients received kidney transplants.
Journal ArticleDOI

Advances in understanding the aetiology of atypical Haemolytic Uraemic Syndrome.

TL;DR: This review analyses the complement proteins and processes that are disturbed in aHUS patients, and outlines the relevance of a prompt genetic/molecular diagnosis for improving clinical management and prognosis.
Journal ArticleDOI

Anticardiolipin Antibodies in Classic Pediatric Hemolytic-Uremic Syndrome: A Possible Pathogenic Role

TL;DR: A pathogenic role cannot be discarded and additional studies should be performed to identify a possible role in the pathogenesis and clinical manifestations of the classic hemolytic-uremic syndrome.
Related Papers (5)